HEPATITIS B

This study monitored the safety of the Hexaxim vaccine, which protects against six diseases including hepatitis B and Hib, after it was given to infants as part of routine care in South Korea. Researchers tracked over 700 infants for about 5-6 weeks after vaccination to record an…

This early-stage study tested the safety and immune response of a new ingredient (called AS37) added to a Hepatitis B vaccine. The trial involved 122 healthy adults aged 18-45 who had never been vaccinated against Hepatitis B. Researchers gave participants two shots one month apa…

This study tested whether giving children fewer hepatitis B vaccine doses provides the same level of protection as the standard three-dose schedule. Researchers compared the immune response in 431 children who received either two or three vaccine doses starting at 2 months old. T…

This early-stage study tested a new drug called ARO-HBV for treating Hepatitis B. It first checked the drug's safety in healthy volunteers, then looked at its effects in people with the virus. The main goal was to see if the drug was safe and how the body processed it, while also…

This study tested a new strategy using faster, on-site tests to screen pregnant women for several sexually transmitted infections (STIs) in Zimbabwe. The goal was to see if this approach was practical, accepted by patients, and could lead to better and quicker treatment. Research…

This study tested a simple way to prevent mothers from passing hepatitis B to their babies during birth. In the Democratic Republic of Congo, 317 pregnant women with hepatitis B received either a real medication or a placebo pill during late pregnancy. All their newborns got a he…

This study aimed to learn more about Hepatitis C virus (HCV) infection by observing people who tested positive for it while donating blood. Researchers followed 805 participants over time to understand how the virus spreads, who develops liver problems, and how infectious people …

This study aimed to find out how many people held in a specific French detention center had HIV, hepatitis B, or hepatitis C. Researchers used rapid tests to screen 350 detainees, as many come from regions where these infections are common and may not know their status. The goal …

This study looked at whether doctors followed guidelines to screen for hepatitis B in COVID-19 pneumonia patients before giving them steroid treatment. Researchers wanted to see if this hidden liver virus could reactivate and cause problems during COVID-19 care. They observed nea…